What Is the Best Predictor of Future Type 2 Diabetes?
- 1 June 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (6) , 1544-1548
- https://doi.org/10.2337/dc06-1331
Abstract
OBJECTIVE—We sought to assess insulin secretion/insulin resistance index in predicting the risk for future type 2 diabetes RESEARCH DESIGN AND METHODS—A total of 1,551 nondiabetic subjects from the San Antonio Heart Study received an oral glucose tolerance test (OGTT) with measurement of plasma glucose and insulin concentrations at 0, 30, 60, and 120 min at baseline and after 7–8 years of follow-up. Insulin secretion/insulin resistance index was calculated as the product of Matsuda index and ΔI0–30/ΔG0–30 or ΔI0–120/ΔG0–120. The discriminatory power of various prediction models for development of type 2 diabetes was tested with the area under the receiver-operating characteristic (ROC) curve. RESULTS—Insulin secretion/insulin resistance index (0- to 30- and 0- to 120-min time periods) had the greatest areas under the ROC curve (0.85 and 0.86, respectively), which were significantly greater than the 2-h plasma glucose concentration during the OGTT or the San Antonio Diabetes Prediction Model (SADPM) (P < 0.001 and P < 0.0001, respectively). A model based on the combination of the SADPM and a modified version of the insulin secretion/insulin resistance index or 1-h plasma glucose concentration had equal power to predict the risk for future type 2 diabetes compared with the insulin secretion/insulin resistance index. CONCLUSIONS—The insulin secretion/insulin resistance index is useful as a predictor of future development of type 2 diabetes. A model based on the combination of the SADPM and either a modified version of the insulin secretion/insulin resistance index or 1-h plasma glucose concentration can equally predict future type 2 diabetes.Keywords
This publication has 29 references indexed in Scilit:
- Identifying Individuals at High Risk for DiabetesDiabetes Care, 2005
- Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and interventionDiabetic Medicine, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Evaluation of Simple Indices of Insulin Sensitivity and Insulin Secretion for Use in Epidemioiogic StudiesAmerican Journal of Epidemiology, 2000
- Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesDiabetes, 1997
- Trends in acute myocardial infarction coronary heart disease death in the United StatesJournal of the American College of Cardiology, 1994
- The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM ParentsDiabetes, 1992
- Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community surveyJAMA, 1989
- Significance of impaired glucose tolerance in an Asian Indian population: a follow-up studyDiabetes Research and Clinical Practice, 1986
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985